Bristol Myers Squibb to Participate in Citi’s 15th Annual BioPharma Virtual Conference

NEW YORK--Bristol Myers Squibb (NYSE: BMY) today announced that the company will take part in a fireside chat at Citi’s 15th Annual BioPharma Virtual Conference, which will be webcast on Tuesday, September 8, 2020. Samit Hirawat, MD, EVP, Chief Medical Officer and Rupert Vessey, MA, BM BCh, FRCP, DPhil, EVP of Research and Early Development will answer questions about the company at 12:15 p.m. EDT.

Investors and the general public are invited to listen to a live webcast of the session at http://investor.bms.com. An archived edition of the session will be available later that day.

About Bristol Myers Squibb

Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.

CONTACT:
BRISTOL MYERS SQUIBB
MEDIA:
MEDIA@BMS.COM
609-252-3345

INVESTOR RELATIONS:
TIM POWER
609-252-7509
TIMOTHY.POWER@BMS.COM

NINA GOWOREK
908-673-9711
NINA.GOWOREK@BMS.COM

Related Posts

Subscribe Our Newsletter